Nuvectis Pharma, Inc. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Nuvectis Pharma, Inc. stock issued during period, value, new issues for the quarter ending 2025-06-30 was $521.00K, a 68.84% decline year-over-year.
- Nuvectis Pharma, Inc. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $1.46M, a 32.33% increase year-over-year.
- Nuvectis Pharma, Inc. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $1.67M, a 46.24% decline year-over-year.
- Nuvectis Pharma, Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $4.70M.
- Nuvectis Pharma, Inc. stock issued during period, value, new issues for fiscal 2024 was $11.65M, a 127.88% increase from fiscal 2023.
- Nuvectis Pharma, Inc. stock issued during period, value, new issues for fiscal 2023 was $5.11M, a 60.99% decline from fiscal 2022.
- Nuvectis Pharma, Inc. stock issued during period, value, new issues for fiscal 2022 was $13.11M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-06-30 | $521.00K 10-Q · filed 2025-11-04 | |
| 2024-12-31 | $11.65M 10-K · filed 2025-02-25 | |
| 2024-09-30 | $1.46M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $1.67M 10-Q · filed 2024-11-05 | |
| 2024-03-31 | $4.70M 10-Q · filed 2024-11-05 | |
| 2023-12-31 | $5.11M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $1.10M 10-Q · filed 2024-11-05 | |
| 2023-06-30 | $3.11M 10-Q · filed 2024-11-05 | |
| 2022-12-31 | $13.11M 10-K · filed 2024-03-05 | |
| 2022-03-31 | $13.11M 10-Q · filed 2023-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |